Tucson · Seed–Series B · 4 people tracked
Investment thesis
BlueStone Venture Partners invests in life sciences and information technology companies that operate outside the traditional venture capital hubs of the United States, with a particular focus on the desert Southwest. The firm believes the region holds overlooked opportunities supported by strong universities, unique research centers, and significant infrastructure, yet underserved by venture capital. Leveraging its management expertise, established deal pipelines, and relationships with industry-leading advisors and co-investors, the firm aims to identify promising companies and create value for its investors.
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from the firm's website & public directories
What they invest in
from 9 of 9 portfolio companiesHealthtech ×7Biotech ×6Medical Devices ×4Deep Tech ×2Digital Health ×2Advanced Manufacturing ×1AI & Machine Learning ×1Hardware ×1
HQs:United States×4
Investments · 9 tracked
founders shown can be your intro path
Akadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products.
Advanced ManufacturingBiotechDeep TechHealthtechMedical DevicesAnn Arbor, US
Kalyan Handique(Executive Officer, Director)John Younger(Executive Officer, Director)James Militello(Executive Officer)
BoardJeffrey S. Williams(Director)Paul D'Amato(Director)Dan Kidle(Director)in
Co-investorsArboretum VenturesBeringeaBerkeley CatalysteLab VenturesID VenturesInvest Michigan+5 more
BiotechScottsdale, US
Todd Levine(Executive Officer, Director)Richard J. Morello(Executive Officer, Director)Peter Harris(Executive Officer, Director)Christopher Gibbons(Director)
BoardJack Seaver(Director)Enrique Carrazana(Director)
Co-investorsTop Corner Capital
Elucid offers PlaqueIQ, a non-invasive CT-based plaque analysis tool for cardiologists and radiologists to assess coronary and carotid plaque composition and enable patient-specific treatment pathways for cardiovascular disease prevention.
AI & Machine LearningHealthtechMedical Devices
Co-investorsAngel Physicians FundAphelion Capital
GammaTile Therapy, a surgically targeted radiation therapy for operable brain tumors
HealthtechTempe, US
David G. Brachman(Executive Officer, Director)Per Langoe(Executive Officer, Director)James Leech(Executive Officer)Matthew E. Likens(Executive Officer, Director)
BoardGeoff Pardo(Director)inPrattipati Laxminarain(Director)
Co-investorsAccelmed PartnersFemHealth VenturesEvidity Health CapitalGilde HealthcareMedical Technology Venture PartnersMedTech Venture Partners+2 more
GammaTile is an FDA-cleared, bioresorbable collagen tile embedded with radiation sources, implanted during brain tumor removal surgery to deliver targeted radiation at the surgical site.
BiotechHealthtechMedical Devices
Co-investorsAccelmed PartnersEvidity Health CapitalFemHealth Ventures
NTx Bio develops automated, continuous-flow cell-free biomanufacturing systems—including its NTxscribe bioreactors and proprietary enzymes—for on-demand, benchtop production of RNA (mRNA and saRNA) and proteins.
BiotechDeep TechHardware
Co-investorsAnzu Partners
Paradigm develops diagnostic tests for cancer, including assessments of hereditary risk, screening for the presence of cancer, and analysis of the genomic alterations in a patient's tumor to help guide treatment decisions.
BiotechDigital HealthHealthtech
Co-investorsNew Science Ventures
PreludeDx develops DCISionRT, a biomarker-based diagnostic test for ductal carcinoma in situ (DCIS) breast cancer that helps physicians predict a patient's recurrence risk and whether they would benefit from radiation therapy after breast-conserving surgery.
BiotechHealthtechMedical Devices
Co-investorsEvidity Health Capital
Pyx Health provides a member engagement and activation solution for health plans, combining in-home fresh food delivery, human care teams, and a digital app to address non-medical drivers of health such as loneliness and food needs.
Digital HealthHealthtechWellness & FitnessTucson, US
Cynthia Jordan(Executive Officer, Director)
Co-investorsArizona Founders FundS2G Investments
Portfolio news
latest coverage across their companiesCND Life Sciences · infotechlead.com · Aug 24, 2026
NTx Bio · dallasnews.com · Jan 27, 2026
Akadeum Life Sciences · finsmes.com · Jun 4, 2025
Frequently asked questions
- How many investments has BlueStone Venture Partners made?
- BlueStone Venture Partners has 8 tracked investments.
- What stage does BlueStone Venture Partners invest at?
- BlueStone Venture Partners invests at the Seed, Series A, Series B stages.
- What is BlueStone Venture Partners's typical check size?
- BlueStone Venture Partners typically writes checks of $250K – $1M.
- What sectors does BlueStone Venture Partners focus on?
- BlueStone Venture Partners focuses on Biotech, Digital Health, Enterprise Software, Healthtech, Medical Devices, New Materials.
- Where is BlueStone Venture Partners located?
- BlueStone Venture Partners is headquartered in Tucson, US.
- Who does BlueStone Venture Partners co-invest with?
- BlueStone Venture Partners most often shares deals with Evidity Health Capital, Anzu Partners, Arboretum Ventures, among 21 tracked co-investors.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
New Science Ventures (NSV) is a venture capital firm based in Connecticut and London that backs companies applying novel scientific approaches in the life sciences and information technology sectors.
OUP (Osage University Partners) is a venture firm that invests in science-driven startups commercializing deep technology innovations emerging from university and breakthrough research.
New Alliance Capital is a Shanghai-based private equity and venture capital firm founded in 2008, focused on technology-driven sectors. Its backers include state-owned enterprise groups, insurance capital, fund-of-funds, government guidance funds, and listed companies.